Rani Therapeutics Holdings Cash Flow Statement (2020-2025) | RANI

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -2.71M-2.88M-5.76M-5.60M-5.49M-28.70M-13.30M-13.83M-15.97M-16.21M-17.37M-16.83M-18.66M-18.33M-14.05M-14.78M-13.36M-12.72M-15.72M-12.74M-11.22M-7.91M
Depreciation and Depletion 0.14M0.13M0.12M0.12M0.11M0.12M0.14M0.13M
Share-based Compensation 0.45M0.28M18.70M3.16M2.90M3.98M4.40M4.50M4.42M5.14M4.97M4.49M3.87M4.13M4.04M3.99M3.92M3.29M2.34M
Gains from Sales and Divestitures 0.02M0.02M0.02M0.03M0.27M0.27M0.59M0.32M0.39M0.16M0.22M0.27M
Gains from Investment Securities -0.67M0.72M0.22M2.29M0.09M0.12M0.01M0.03M4.73M0.02M0.02M-0.01M
Non-cash Items 0.06M0.98M27.80M0.60M0.85M13.38M21.80M5.16M16.40M6.46M6.40M
Cash from Operations 0.67M-6.70M-4.05M-5.63M-11.12M-11.45M-9.36M-10.33M-12.20M-14.63M-12.15M-12.30M-14.30M-12.48M-9.40M-9.03M-8.41M-8.66M-8.15M-5.80M-5.06M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.16M0.16M0.21M0.32M0.70M0.54M0.61M0.47M0.38M0.25M0.70M0.48M0.48M0.48M0.47M
Amortization of Deferred Charges 0.02M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M0.06M
Depreciation & Amortization (CF) 0.14M0.14M0.13M0.12M0.11M0.11M0.12M0.14M0.17M0.19M0.19M0.22M0.23M0.25M0.26M0.26M0.27M0.25M0.24M0.22M
Change in Working Capital
Change in Receivables -3.05M0.60M-1.03M
Change in Account Payables 0.26M-3.71M0.39M0.35M-0.06M-0.13M0.08M0.13M0.17M-0.21M0.08M-0.41M0.40M-0.66M0.16M-0.30M1.06M-0.21M0.16M0.28M0.67M
Change in Accured Expenses 0.05M-0.38M0.82M0.73M0.79M-1.61M0.65M0.80M0.94M-1.78M0.32M1.38M-0.08M-2.17M0.88M-0.20M-0.63M0.29M0.17M0.39M-0.55M
Investing Activities
Capital Expenditures 0.26M0.10M0.14M0.05M0.22M0.25M0.38M0.46M0.53M0.25M0.34M0.48M0.17M0.05M0.06M0.12M0.03M0.05M0.04M
Change in Acquisitions & Divestments 3.00M23.00M35.00M23.50M22.85M20.35M18.20M18.70M20.30M21.00M5.75M
Cash from Investing Activities -0.26M-0.10M-0.14M-0.27M-0.25M-0.38M-71.35M-0.46M4.12M0.79M11.67M13.27M10.29M6.53M0.47M2.52M18.23M5.71M
Financing Activities
Other financing activities -0.30M2.19M-1.89M0.11M0.15M
Debt Issuance and Repayment
Long-Term Debt Issuances 2.78M1.72M14.67M14.90M
Long-Term Debt Repayments 1.25M3.75M3.75M3.75M3.75M
Change in Capital Stock
Shares Issued 0.01M-0.57M0.05M-0.15M0.13M-0.13M0.08M-0.04M0.12M-0.08M8.88M-0.05M0.04M3.90M-0.07M
Preferred Shares Issued 68.49M6.32M
Misc.
Cash from Financing Activities 2.78M68.65M7.75M-1.58M71.55M-0.57M0.05M14.08M14.87M0.01M0.08M0.05M0.10M0.12M0.14M7.70M5.62M-3.73M0.19M-1.01M
Change in Cash 3.45M61.69M3.60M-7.35M60.43M-12.29M-9.61M-10.66M-69.46M-0.21M-8.02M-11.43M-2.58M0.89M1.01M-2.36M-0.24M-0.52M6.35M0.10M-6.07M
Free Cash Flow 0.67M-6.96M-4.15M-5.76M-11.17M-11.67M-9.61M-10.71M-12.65M-15.16M-12.40M-12.64M-14.78M-12.64M-9.45M-9.09M-8.54M-8.69M-8.20M-5.83M-5.06M
Net Cash Flow 3.45M61.69M3.60M-7.35M60.43M-12.29M-9.61M-10.66M-69.46M-0.21M-8.02M-11.43M-2.58M0.89M1.01M-2.36M-0.24M-0.52M6.35M0.10M-6.07M